The CARTISTEM® procedure is simple, fast and effective as shown in the following video:
CARTISTEM® treatment is an alternative to artificial knee-replacement surgery.
Approved product-label by the Korean Regulatory Authority (MFDS) CARTISTEM® reads:
“CARTISTEM® is indicated for the treatment of articular cartilage defects in patients with osteoarthritis (ICRS grade IV) as a result of degenerative disease or repeated trauma for anyone over the age of 18 years.”
In 2015, it was estimated that 1 million total knee replacements (TKRs) were performed in the US and, with an ever-aging population, a projected estimate of 3.5 million will be done by 2030. TKRs are the only currently approved treatment for osteoarthritis of the knee due to degeneration of knee cartilage or repeated trauma. However, a recent study showed that the median time to revision for patients who underwent a TKR surgery younger than 60 years of age was 4.4 years.
Read Study published in Lancet Medical Journal.
Thousands of knee osteoarthritis patients have regained pain-free mobility with CARTISTEM®
CARTISTEM® is a ground-breaking treatment for patients with osteoarthritis of the knee as a result of degenerative disease or trauma — CARTISTEM® is the viable alternative to a total or partial knee replacement.
Following recovery from the anaesthetic, the patient rests overnight with the leg held in an extended position by a knee-brace. After surgery, the patient is mobile but must avoid weight-bearing for 4 – 8 weeks or as advised by the Korean surgeon to allow for healing and natural regeneration of the patient’s own cartilage.